These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23332170)

  • 1. Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy.
    Nash KR; Lee DC; Hunt JB; Morganti JM; Selenica ML; Moran P; Reid P; Brownlow M; Guang-Yu Yang C; Savalia M; Gemma C; Bickford PC; Gordon MN; Morgan D
    Neurobiol Aging; 2013 Jun; 34(6):1540-8. PubMed ID: 23332170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically enhancing the expression of chemokine domain of CX
    Bemiller SM; Maphis NM; Formica SV; Wilson GN; Miller CM; Xu G; Kokiko-Cochran ON; Kim KW; Jung S; Cannon JL; Crish SD; Cardona AE; Lamb BT; Bhaskar K
    J Neuroinflammation; 2018 Sep; 15(1):278. PubMed ID: 30253780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy.
    Joly-Amado A; Hunter J; Quadri Z; Zamudio F; Rocha-Rangel PV; Chan D; Kesarwani A; Nash K; Lee DC; Morgan D; Gordon MN; Selenica MB
    Front Immunol; 2020; 11():997. PubMed ID: 32508844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS-Wide over Expression of Fractalkine Improves Cognitive Functioning in a Tauopathy Model.
    Finneran DJ; Morgan D; Gordon MN; Nash KR
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):312-325. PubMed ID: 30499006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo.
    DeVos SL; Corjuc BT; Commins C; Dujardin S; Bannon RN; Corjuc D; Moore BD; Bennett RE; Jorfi M; Gonzales JA; Dooley PM; Roe AD; Pitstick R; Irimia D; Frosch MP; Carlson GA; Hyman BT
    Brain; 2018 Jul; 141(7):2194-2212. PubMed ID: 29733334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis.
    Lastres-Becker I; Innamorato NG; Jaworski T; Rábano A; Kügler S; Van Leuven F; Cuadrado A
    Brain; 2014 Jan; 137(Pt 1):78-91. PubMed ID: 24277722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy.
    Spires-Jones TL; Friedman T; Pitstick R; Polydoro M; Roe A; Carlson GA; Hyman BT
    Neurosci Lett; 2014 Mar; 562():63-8. PubMed ID: 24462887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.
    Maphis N; Xu G; Kokiko-Cochran ON; Jiang S; Cardona A; Ransohoff RM; Lamb BT; Bhaskar K
    Brain; 2015 Jun; 138(Pt 6):1738-55. PubMed ID: 25833819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated CX3CL1/Smad2 Signals Prevent Neuronal Loss and Alzheimer's Tau Pathology-Mediated Cognitive Dysfunction.
    Fan Q; He W; Gayen M; Benoit MR; Luo X; Hu X; Yan R
    J Neurosci; 2020 Jan; 40(5):1133-1144. PubMed ID: 31822518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ordered assembly of tau is the gain-of-toxic function that causes human tauopathies.
    Goedert M
    Alzheimers Dement; 2016 Oct; 12(10):1040-1050. PubMed ID: 27686274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A seeding based cellular assay of tauopathy.
    Xu Y; Martini-Stoica H; Zheng H
    Mol Neurodegener; 2016 Apr; 11():32. PubMed ID: 27112488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Picalm reduction exacerbates tau pathology in a murine tauopathy model.
    Ando K; De Decker R; Vergara C; Yilmaz Z; Mansour S; Suain V; Sleegers K; de Fisenne MA; Houben S; Potier MC; Duyckaerts C; Watanabe T; Buée L; Leroy K; Brion JP
    Acta Neuropathol; 2020 Apr; 139(4):773-789. PubMed ID: 31925534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotrophin receptor p75 mediates amyloid β-induced tau pathology.
    Shen LL; Li WW; Xu YL; Gao SH; Xu MY; Bu XL; Liu YH; Wang J; Zhu J; Zeng F; Yao XQ; Gao CY; Xu ZQ; Zhou XF; Wang YJ
    Neurobiol Dis; 2019 Dec; 132():104567. PubMed ID: 31394202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model.
    Fox LM; William CM; Adamowicz DH; Pitstick R; Carlson GA; Spires-Jones TL; Hyman BT
    J Neuropathol Exp Neurol; 2011 Jul; 70(7):588-95. PubMed ID: 21666499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid β accelerates phosphorylation of tau and neurofibrillary tangle formation in an amyloid precursor protein and tau double-transgenic mouse model.
    Seino Y; Kawarabayashi T; Wakasaya Y; Watanabe M; Takamura A; Yamamoto-Watanabe Y; Kurata T; Abe K; Ikeda M; Westaway D; Murakami T; Hyslop PS; Matsubara E; Shoji M
    J Neurosci Res; 2010 Dec; 88(16):3547-54. PubMed ID: 20936700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroinflammation and fractalkine signaling in Alzheimer's disease.
    Finneran DJ; Nash KR
    J Neuroinflammation; 2019 Feb; 16(1):30. PubMed ID: 30744705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of tau pathology by the microglial fractalkine receptor.
    Bhaskar K; Konerth M; Kokiko-Cochran ON; Cardona A; Ransohoff RM; Lamb BT
    Neuron; 2010 Oct; 68(1):19-31. PubMed ID: 20920788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.